- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 26.61M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 26.31M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 24.32M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$5M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$75M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $64M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $66M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $250M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $145M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $151M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $164M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $217M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $223M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $156M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $223M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $156M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.27 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$2.43 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.27 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$2.43 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $6M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $22M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$4M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$59M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$6M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$53M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $22M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $6M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $30M |
| Revenue | Q1 2025 · Mar 31, 2024 | $36M |